bcma-targeted bites for multiple myeloma
Published 3 years ago • 305 plays • Length 8:13Download video MP4
Download video MP3
Similar videos
-
11:06
bites for the treatment of multiple myeloma
-
1:38
using bcma-targeting agents in earlier lines of treatment for multiple myeloma
-
0:41
fcrh5 & gprc5d bispecific antibodies: antigen targets beyond bcma for multiple myeloma
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
1:55
updates in immunotherapy for multiple myeloma: bites & novel targets
-
3:06
multiple myeloma: adcs and bites
-
5:52
bcma targeting agents in myeloma
-
3:41
can novel immunotherapies cure multiple myeloma?
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
6:48
key trials in multiple myeloma presented at ash 2023: take home messages
-
2:41
addressing differences in how black patients with myeloma may present compared to other ethnicities
-
1:48
mechanisms behind the loss of bcma in multiple myeloma & options for patients
-
11:01
targeting bcma for r/r myeloma
-
1:37
integrating bcma-targeted immunotherapies into challenging multiple myeloma cases
-
1:53
infections following anti-bcma bispecific antibodies for multiple myeloma
-
3:28
the importance of bcma-targeting adcs and bispecific antibodies in r/r multiple myeloma
-
1:47
abnormal serum immunofixation patterns following bcma car-t in multiple myeloma
-
1:16
the value of bcma-targeting agents in treating patients with penta-refractory multiple myeloma
-
1:10
the importance of bcma, fcrh5 and gprc5d in multiple myeloma
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
1:29
sequencing bcma-targeted therapies in myeloma